Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 1, 1996, Pages 30-35

  Hori, Naoki ^a   Okanoue, Takeshi ^a   Mori, Takashi ^a   Kashima, Kei ^a   Nishimura, Masato ^a   Nanbu, Akira ^a   Yoshimura, Manabu ^c   Takahashi, Hakuo ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c NONE

Author keywords

Human study; Hypercirculation; Liver cirrhosis; Nitrate ion; Nitric oxide

Indexed keywords

NITRATE; NITRIC OXIDE; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLOOD; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; THROMBOCYTE; URINE;

ADULT; AGED; BLOOD PLATELETS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; SERUM ALBUMIN;

EID: 0029690124     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb03058.x     Document Type: Article

References (30)

1. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 1991; 237: 776-8.
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 387: 524-6.
3. Claris J, Jimenez W, Ros J et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide. Hepatology 1992; 15: 343-9.
4. Fernandez M, Casadevall M, Pizcueta MP et al. Inadequate release of nitric oxide (NO) and splanchnic and systemic vasodilatation in portal hypertension. J. Hepatol. 1992; 16: S34 (Abstract).
5. Pizcueta MP, Pique JM, Bosch J et al. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br. J. Pharmacol. 1992; 105: 184-90.
6. Pizcueta MP, Pique JM, Fernandez M et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-15.
7. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992; 103: 235-9.
8. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: Reversal by nitric oxide blockade. Am. J. Physiol. 1992; 262: G996-1001.
9. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750-4.
10. Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 16, 1043-8.
11. Yoshida K, Kasama K. Biotransformation of nitric oxide. Environ. Health Perspect. 1987; 73: 201-6.
12. Fratacci MD, Frostell CG, Chen TY et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991; 75: 927-31.
13. Stuehr DJ, Narletta MA. Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl Acad. Sci. USA 1985; 82: 7738-42.
14. Toda N, Kitamura Y, Okamura T. Neural mechanism of hypertension nitric oxide synthase inhibitor in dogs. Hypertension 1993; 21: 3-8.
15. Moncada S, Palmer RMJ, Higgs, EA. The biological significance of nitric oxide formation from L-arginine. Biochem. Soc. Trans. 17: 642-4.
16. Takahashi H, Nakanishi T, Nishimura M et al. Measurement of serum levels of nitrate ions in men and women: Implication of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis. J. Cardiovasc. Pharmacol. 1992; 20 (Suppl. 12): S214-16.
17. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl Acad. Sci. USA 1990; 87: 10 043-7.
18. Leone AM, Palmer RM, Knowles RG et al. Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline. J. Biol. Chem. 1991; 266: 23 790-5.
19. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109-42.
20. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 1992; 26: 48-57.
21. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991; 17: 187-93.
22. Rubanyi GM, Romero JC, Vanhoutte APM. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol. 1986; 250: H1145-9.
23. Guarner C, Soriano G, Tomas A et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 1993; 18: 1139-43.
24. Sherlock S. Classification and functional aspects of portal hypertension. Am. J. Surg. 1993; 127: 121-8.
25. Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-74.
26. Charles LS, LaRochelle J. Venous and arterial endothelia: Different dilator abilities in dog vessels. Circ. Res. 1987; 60: 626-30.
27. Mittal MK, Lee FY, Sieber CC, Groszmann RJ. Nitric oxide modulation of the intrahepatic circulation in normal rats. Hepatology 1992; 16: 123A (Abstract).
28. Mittal MK, Lee FY, Groszmann RJ. Role of nitric oxide in the intrahepatic portal circulation of cirrhotic rats. Gastroenterology 1993; 104: 956A (Abstract).
29. Hori N, Takahashi H, Okanoue T et al. Augmented endogenous nitric oxide production in partial portal vein-ligated rats. Clin. Exp. Pharmacol. Physiol. 1995; 22: 506-11.
30. Cahill PA, Wu YP, Sitzmann JV. Nitric oxide synthase activity in portal hypertension. Hepatology 1993; 18: 141A (Abstract).